4.6 Article

Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Fanconi Syndrome Secondary to Sodium Valproate Therapy: Experience and Literature Review

Daniela Andrea Sturla Alvarez et al.

Summary: This study describes patients with severe psychomotor retardation treated with sodium valproate (VPA) and diagnosed with Fanconi syndrome (FS). A total of 42 patients were studied, mostly males with a median age of 6 years. Severe psychomotor retardation was common among these patients, and many of them used feeding devices. Bone complications were observed in 15 patients.

PEDIATRIC NEUROLOGY (2022)

Article Neurosciences

Abnormalities of mitochondrial dynamics and bioenergetics in neuronal cells from CDKL5 deficiency disorder

Nicole J. Van Bergen et al.

Summary: CDKL5 deficiency disorder (CDD) is a rare neurodevelopmental disorder caused by pathogenic variants in the CDKL5 gene, predominantly affecting females and potentially resulting in severe intellectual disability. Research suggests that mitochondrial defects in CDD patients may contribute to the disease pathology, highlighting the importance of investigating mitochondrial dysfunction as a potential focus for targeted treatments for CDD.

NEUROBIOLOGY OF DISEASE (2021)

Article Medicine, General & Internal

Initial Management of Seizure in Adults

Phil E. M. Smith

Summary: Initial management of seizure in adults involves detailed history taking and eyewitness account for diagnosis, with medication choice tailored to seizure type, patient's coexisting conditions, and childbearing potential, generally not prescribed after a single seizure.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Pediatrics

Fanconi Syndrome

John W. Foreman

PEDIATRIC CLINICS OF NORTH AMERICA (2019)

Review Pediatrics

The effects of sodium valproate on the renal function of children with epilepsy

Mark Jonathan Knights et al.

PEDIATRIC NEPHROLOGY (2014)

Article Clinical Neurology

Fever of Unknown Origin as the Initial Manifestation of Valproate-Induced Fanconi Syndrome

Fumihito Nozaki et al.

PEDIATRIC NEUROLOGY (2014)

Article Clinical Neurology

Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children

Markus Rauchenzauner et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)

Article Medicine, General & Internal

BRIEF REPORT A Loss-of-Function Mutation in NaPi-IIa and Renal Fanconi's Syndrome

Daniella Magen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Pediatrics

Secondary renal Fanconi syndrome caused by valproate therapy

T Watanabe et al.

PEDIATRIC NEPHROLOGY (2005)

Article Medical Laboratory Technology

Topiramate increases biochemical risk of nephrolithiasis

EJ Lamb et al.

ANNALS OF CLINICAL BIOCHEMISTRY (2004)

Review Urology & Nephrology

Drug-induced Fanconi's syndrome

H Izzedine et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2003)

Article Urology & Nephrology

Drug-induced acute interstitial nephritis

J Rossert

KIDNEY INTERNATIONAL (2001)

Article Pediatrics

Renal tubular dysfunction in epileptic children on valproic acid therapy

S Altunbasak et al.

PEDIATRIC NEPHROLOGY (2001)